Cargando…

Distinctive Oculomotor Behaviors in Alzheimer's Disease and Frontotemporal Dementia

Oculomotor behavior can provide insight into the integrity of widespread cortical networks, which may contribute to the differential diagnosis between Alzheimer's disease and frontotemporal dementia. Three groups of patients with Alzheimer's disease, behavioral variant of frontotemporal de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lage, Carmen, López-García, Sara, Bejanin, Alexandre, Kazimierczak, Martha, Aracil-Bolaños, Ignacio, Calvo-Córdoba, Alberto, Pozueta, Ana, García-Martínez, María, Fernández-Rodríguez, Andrea, Bravo-González, María, Jiménez-Bonilla, Julio, Banzo, Ignacio, Irure-Ventura, Juan, Pegueroles, Jordi, Illán-Gala, Ignacio, Fortea, Juan, Rodríguez-Rodríguez, Eloy, Lleó-Bisa, Alberto, García-Cena, Cecilia E., Sánchez-Juan, Pascual
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7891179/ https://www.ncbi.nlm.nih.gov/pubmed/33613262 http://dx.doi.org/10.3389/fnagi.2020.603790

Ejemplares similares

APP‐derived peptides reflect neurodegeneration in frontotemporal dementia
por: Illán‐Gala, Ignacio, et al.
Publicado: (2019)

Sleep Time Estimated by an Actigraphy Watch Correlates With CSF Tau in Cognitively Unimpaired Elders: The Modulatory Role of APOE
por: López-García, Sara, et al.
Publicado: (2021)

Ganglion cell layer thinning in prodromal Alzheimer's disease defined by amyloid PET
por: López-de-Eguileta, Alicia, et al.
Publicado: (2019)

Evaluation of choroidal thickness in prodromal Alzheimer’s disease defined by amyloid PET
por: López-de-Eguileta, Alicia, et al.
Publicado: (2020)

Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia
por: Zhu, Nuole, et al.
Publicado: (2021)

Correction: Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia
por: Zhu, Nuole, et al.
Publicado: (2023)

Challenges associated with biomarker-based classification systems for Alzheimer's disease
por: Illán-Gala, Ignacio, et al.
Publicado: (2018)

The retinal ganglion cell layer reflects neurodegenerative changes in cognitively unimpaired individuals
por: López-de-Eguileta, Alicia, et al.
Publicado: (2022)

Weight loss in the healthy elderly might be a non-cognitive sign of preclinical Alzheimer's disease
por: Jimenez, Amanda, et al.
Publicado: (2017)

Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration
por: Cervantes González, Alba, et al.
Publicado: (2022)

AMYQ: An index to standardize quantitative amyloid load across PET tracers
por: Pegueroles, Jordi, et al.
Publicado: (2021)

Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer’s pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform
por: Martínez-Dubarbie, Francisco, et al.
Publicado: (2023)

Pathophysiological Underpinnings of Extra-Motor Neurodegeneration in Amyotrophic Lateral Sclerosis: New Insights From Biomarker Studies
por: Reyes-Leiva, David, et al.
Publicado: (2022)

Different pattern of CSF glial markers between dementia with Lewy bodies and Alzheimer’s disease
por: Morenas-Rodríguez, Estrella, et al.
Publicado: (2019)

Detection of early Alzheimer's disease in MCI patients by the combination of MMSE and an episodic memory test
por: Pozueta, Ana, et al.
Publicado: (2011)

Caspase-1 genetic variation is not associated with Alzheimer's disease risk
por: Vázquez-Higuera, José Luis, et al.
Publicado: (2010)

Cortical microstructure in primary progressive aphasia: a multicenter study
por: Illán-Gala, Ignacio, et al.
Publicado: (2022)

Correction: Cortical microstructure in primary progressive aphasia: a multicenter study
por: Illán-Gala, Ignacio, et al.
Publicado: (2023)

Neuroinflammation-Related Proteins NOD2 and Spp1 Are Abnormally Upregulated in Amyotrophic Lateral Sclerosis
por: de Luna, Noemí, et al.
Publicado: (2022)

Genetic variation in the tau protein phosphatase-2A pathway is not associated with Alzheimer's disease risk
por: Vázquez-Higuera, José L, et al.
Publicado: (2011)

Sex differences in the behavioral variant of frontotemporal dementia: A new window to executive and behavioral reserve
por: Illán‐Gala, Ignacio, et al.
Publicado: (2021)

YKL-40 (Chitinase 3-like I) is expressed in a subset of astrocytes in Alzheimer’s disease and other tauopathies
por: Querol-Vilaseca, Marta, et al.
Publicado: (2017)

Diagnostic Utility of Measuring Cerebral Atrophy in the Behavioral Variant of Frontotemporal Dementia and Association With Clinical Deterioration
por: Illán-Gala, Ignacio, et al.
Publicado: (2021)

DYRK1A genetic variants are not linked to Alzheimer's disease in a Spanish case-control cohort
por: Vázquez-Higuera, José Luis, et al.
Publicado: (2009)

Downregulation of miR-335-5P in Amyotrophic Lateral Sclerosis Can Contribute to Neuronal Mitochondrial Dysfunction and Apoptosis
por: De Luna, Noemi, et al.
Publicado: (2020)

Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease
por: Garbutt, Siobhan, et al.
Publicado: (2008)

The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders
por: Alcolea, Daniel, et al.
Publicado: (2019)

Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome
por: Bejanin, Alexandre, et al.
Publicado: (2021)

Decreased CX3CL1 Levels in the Cerebrospinal Fluid of Patients With Alzheimer’s Disease
por: Perea, Juan R., et al.
Publicado: (2018)

Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer’s disease in adults with Down syndrome
por: Lleó, Alberto, et al.
Publicado: (2021)

Association of biological sex with clinical outcomes and biomarkers of Alzheimer’s disease in adults with Down syndrome
por: Iulita, M Florencia, et al.
Publicado: (2023)

Applied computer sciences in engineering: 5th workshop on engineering applications, WEA 2018, Medellín, Colombia, October 17-19, 2018, proceedings, part I
por: Figueroa-García, Juan Carlos, et al.
Publicado: (2018)

Cerebrospinal fluid Presenilin-1 increases at asymptomatic stage in genetically determined Alzheimer’s disease
por: Sogorb-Esteve, Aitana, et al.
Publicado: (2016)

Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
por: Fortea, Juan, et al.
Publicado: (2020)

Cp(2)TiCl/D(2)O/Mn, a formidable reagent for the deuteration of organic compounds
por: Rosales, Antonio, et al.
Publicado: (2016)

Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in a Giant Left Pectoral Muscle Plasmacytoma and Multiple Myeloma Case
por: Martínez-Amador, Néstor, et al.
Publicado: (2019)

Primary ectopic frontotemporal craniopharyngioma
por: Ortega-Porcayo, Luis Alberto, et al.
Publicado: (2015)

Obesity impacts brain metabolism and structure independently of amyloid and tau pathology in healthy elderly
por: Pegueroles, Jordi, et al.
Publicado: (2020)

Neural correlates of episodic memory in adults with Down syndrome and Alzheimer’s disease
por: Benejam, Bessy, et al.
Publicado: (2022)

Longitudinal Clinical and Cognitive Changes Along the Alzheimer Disease Continuum in Down Syndrome
por: Videla, Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_id77r627te5sqtr6qefcafg9ck